Megan Lerner to Tumor Burden
This is a "connection" page, showing publications Megan Lerner has written about Tumor Burden.
Connection Strength
0.100
-
Optimized monoclonal antibody treatment against ELTD1 for GBM in a G55 xenograft mouse model. J Cell Mol Med. 2020 01; 24(2):1738-1749.
Score: 0.042
-
Oncolytic potential of a novel KGFR tyrosine kinase inhibitor using a KGFR-selective breast cancer xenograft model. Anticancer Res. 2015 Jan; 35(1):47-52.
Score: 0.030
-
Distinguishing patients with stage I lung cancer versus control individuals using serum mass profiling. Cancer Invest. 2014 May; 32(4):136-43.
Score: 0.028